News Medical: Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1 New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ... Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1 News Medical: Calcium channel blockers: A new hope for pregnant women with vasospastic angina Calcium channel blockers: A new hope for pregnant women with vasospastic angina Healio: Patients with HFpEF would benefit more from beta-blockers vs. calcium channel blockers Patients with HFpEF would benefit more from beta-blockers vs.
calcium channel blockers NEW YORK, July 31 (Praxis Press) Cardiovascular outcomes have not been compared in hypertensive patients treated with calcium channel blockers and in patients treated with older drugs. Hansson and ... Findings provide reassurance to physicians and patients about the long-term safety of dihydropyridine calcium channel blockers in the treatment of pancreatic cancer. This was a new user, active ...
calcium channel blockers and heart failure, Patients using some types of systemic anti-hypertensive medications should be monitored for glaucoma. Patients treated with dihydropyridine calcium channel blockers are more likely to develop primary ... Patients on calcium channel blockers (CCBs) had a higher likelihood of glaucoma than their counterparts, according to a population-based, cross-sectional study. Examining data on more than 400,000 ... Calcium channel blocker toxicity represents a significant clinical challenge owing to its multifaceted pathophysiology and potential to precipitate life‐threatening cardiovascular compromise.
calcium channel blockers and heart failure, Overdose ... Healio: Calcium channel blocker use linked to 39% higher odds for glaucoma, no effect on IOP Calcium channel blocker use linked to 39% higher odds for glaucoma, no effect on IOP
